$CUE
Cue Biopharma, Inc.

2019 Q1 Form 10-K Financial Statement

#000156459019007832 Filed on March 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 2017 Q4
Revenue $370.0K $1.143M $0.00
YoY Change 94.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.430M $11.26M $1.410M
YoY Change 101.76% 160.65% 80.77%
% of Gross Profit
Research & Development $8.353M $28.54M $8.900M
YoY Change 43.55% 51.02% 345.0%
% of Gross Profit
Depreciation & Amortization $205.0K $760.0K $130.0K
YoY Change 22.75% 81.14% 116.67%
% of Gross Profit
Operating Expenses $11.80M $39.84M $10.44M
YoY Change 56.83% 110.79% 267.61%
Operating Profit -$11.43M -$38.70M
YoY Change 51.91%
Interest Expense $114.0K $376.0K $0.00
YoY Change 1074208.57%
% of Operating Profit
Other Income/Expense, Net $160.0K $541.3K
YoY Change -16100.0% 1546600.0%
Pretax Income -$11.27M -$38.16M -$10.44M
YoY Change 50.07% 64.22% 267.61%
Income Tax $825.0K
% Of Pretax Income
Net Earnings -$11.27M -$38.98M -$10.44M
YoY Change 49.77% 67.8% 267.61%
Net Earnings / Revenue -3045.14% -3411.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$543.9K -$1.936M -$627.4K
COMMON SHARES
Basic Shares Outstanding 20.73M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.88M $39.26M $63.53M
YoY Change -41.96% -38.25%
Cash & Equivalents $21.91M $20.80M $63.53M
Short-Term Investments $8.966M $18.46M $0.00
Other Short-Term Assets $1.000M $1.350M $1.500M
YoY Change -64.29% -8.78%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $31.97M $40.61M $65.07M
YoY Change -42.84% -37.59%
LONG-TERM ASSETS
Property, Plant & Equipment $2.595M $2.780M $1.691M
YoY Change 7.1% 64.5%
Goodwill
YoY Change
Intangibles $175.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $771.0K $1.970M $198.3K
YoY Change -3.63%
Total Long-Term Assets $13.22M $4.750M $1.889M
YoY Change 289.17% 152.66%
TOTAL ASSETS
Total Short-Term Assets $31.97M $40.61M $65.07M
Total Long-Term Assets $13.22M $4.750M $1.889M
Total Assets $45.19M $45.36M $66.95M
YoY Change -23.83% -32.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.893M $2.040M $1.659M
YoY Change 141.08% 53.38%
Accrued Expenses $2.149M $1.480M $1.151M
YoY Change 616.33% 72.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.57M $6.220M $5.347M
YoY Change 157.88% 16.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.900M $5.170M $0.00
YoY Change
Total Long-Term Liabilities $9.900M $5.170M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.57M $6.220M $5.347M
Total Long-Term Liabilities $9.900M $5.170M $0.00
Total Liabilities $20.45M $11.39M $5.347M
YoY Change 400.73% 112.9%
SHAREHOLDERS EQUITY
Retained Earnings -$83.07M -$32.82M
YoY Change 105.9%
Common Stock $107.8M $94.43M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.74M $33.97M $61.61M
YoY Change
Total Liabilities & Shareholders Equity $45.19M $45.36M $66.95M
YoY Change -23.83% -32.25%

Cashflow Statement

Concept 2019 Q1 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$11.27M -$38.98M -$10.44M
YoY Change 49.77% 67.8% 267.61%
Depreciation, Depletion And Amortization $205.0K $760.0K $130.0K
YoY Change 22.75% 81.14% 116.67%
Cash From Operating Activities -$8.475M -$26.41M -$1.890M
YoY Change -13.16% 116.66% -5.97%
INVESTING ACTIVITIES
Capital Expenditures $19.00K $1.854M -$10.00K
YoY Change -97.18% 80.03% -90.0%
Acquisitions
YoY Change
Other Investing Activities $9.500M -$18.50M $0.00
YoY Change
Cash From Investing Activities $9.481M -$20.35M -$10.00K
YoY Change -1508.77% 1589.18% -90.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 257.0K 4.182M 62.04M
YoY Change -93.26% 313.05%
NET CHANGE
Cash From Operating Activities -8.475M -26.41M -1.890M
Cash From Investing Activities 9.481M -20.35M -10.00K
Cash From Financing Activities 257.0K 4.182M 62.04M
Net Change In Cash 1.263M -42.58M 60.14M
YoY Change -112.11% -187.52% 365.84%
FREE CASH FLOW
Cash From Operating Activities -$8.475M -$26.41M -$1.890M
Capital Expenditures $19.00K $1.854M -$10.00K
Free Cash Flow -$8.494M -$28.27M -$1.880M
YoY Change -18.58% 113.81% -1.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5346656
CY2018Q4 cue Research And Development Contract Liability Noncurrent
ResearchAndDevelopmentContractLiabilityNoncurrent
5174752
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2018Q4 us-gaap Cash
Cash
20800284
CY2017Q4 us-gaap Cash
Cash
63533649
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
18412500
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
50068
CY2017Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
50068
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1347288
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1255796
CY2017Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
225500
CY2018Q4 us-gaap Assets Current
AssetsCurrent
40610140
CY2017Q4 us-gaap Assets Current
AssetsCurrent
65065013
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2781459
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1690539
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1012772
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
150000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
808729
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198282
CY2018Q4 us-gaap Assets
Assets
45363100
CY2017Q4 us-gaap Assets
Assets
66953834
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2035354
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1659207
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1788062
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1151085
CY2018Q4 cue Research And Development Contract Liability Current
ResearchAndDevelopmentContractLiabilityCurrent
2011998
CY2017Q4 cue Research And Development Contract Liability Current
ResearchAndDevelopmentContractLiabilityCurrent
2500000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
381465
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
36364
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6216879
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
20697
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
19460
CY2017Q4 cue Common Stock To Be Issued
CommonStockToBeIssued
671
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
105762891
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
94407895
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10958
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71801161
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32820848
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
33971469
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
61607178
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45363100
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66953834
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20697453
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20734232
CY2018Q2 dei Entity Public Float
EntityPublicFloat
216400000
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19459194
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1142604
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
541345
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19459194
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20697453
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
15174640
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2775363
CY2017 cue Stock To Be Issued During Period Value License Agreement
StockToBeIssuedDuringPeriodValueLicenseAgreement
5036789
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11295211
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4333542
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18900328
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-38696658
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
376008
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
35
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
165337
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
35
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38155313
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23233835
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
825000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-38980313
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-10958
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38991271
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23233835
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10732449
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8008
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4169349
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-10958
CY2017 cue Common Stock To Be Issued Pursuant To License Agreements
CommonStockToBeIssuedPursuantToLicenseAgreements
5036789
CY2018 us-gaap Depreciation
Depreciation
760011
CY2017 us-gaap Depreciation
Depreciation
419568
CY2018 cue Deferred Rent
DeferredRent
-345101
CY2017 cue Deferred Rent
DeferredRent
109091
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7173713
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
2775363
CY2018 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3315
CY2017 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-10677
CY2018 cue Non Cash Investment Income
NonCashInvestmentIncome
-76544
CY2018 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-787272
CY2017 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-58432
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4540321
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.07
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.33
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.00
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.79
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.81
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M19D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M3D
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20134065
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63583717
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4169349
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12500
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14925820
CY2017 cue Increase In Certificate Of Deposit
IncreaseInCertificateOfDeposit
35
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
175000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1854246
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1029942
CY2018 cue Payments For Redemption Of Short Term Investments
PaymentsForRedemptionOfShortTermInvestments
-21000000
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
39500000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20354246
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1204977
CY2017 cue Proceeds From Sale Of Placement Agent And Underwriters Warrants
ProceedsFromSaleOfPlacementAgentAndUnderwritersWarrants
1000
CY2017 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
66155293
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8008
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4159981
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4181849
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62004320
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42583365
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
48657897
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21000352
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
825000
CY2017 cue Fair Value Of Warrants Issued In Connection With Issuance Of Common Stock
FairValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock
4086581
CY2017 cue Public Offering Costs Included In Accounts Payable Or Accrued Expenses
PublicOfferingCostsIncludedInAccountsPayableOrAccruedExpenses
150099
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
67477
CY2018 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassification</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:10pt;text-indent:5.48%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts previously reported in current liabilities for the prior period have been reclassified to the current period presentation to segregate accounts payable and accrued liabilities to conform with current period presentation.&nbsp;&nbsp;Also, certain amounts previously reported in research and development contract advances have been reclassified to the current period presentation to combine research and development contract advances and prepaid expenses. There was no impact to reported net loss.&nbsp;&nbsp;The reclassifications did not have a material impact on previously reported financial statements.</p>
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:10pt;text-indent:5.48%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include estimates related to revenue, the accounting for potential liabilities and accrued expenses, the assumptions utilized in valuing stock-based compensation issued for services, the realization of deferred tax assets, and the useful life with respect to long-lived assets and intangibles. Actual results could differ from those estimates.</p> <p style="margin-bottom:0pt;margin-top:10pt;text-indent:5.48%;font-size:10pt;">&nbsp;</p>
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
661153
CY2018Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1195749
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.86
CY2018 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2018 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-31
CY2018Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
39213000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
150000
CY2018 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P15Y
CY2018 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
58000
CY2017 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
16000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5792762
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3984662
CY2018Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10547628
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18412500
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18423458
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10958
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0
CY2018 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
612
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4147398
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2351692
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1365939
CY2017Q4 cue Accrued Contract Manufacturing Services Current
AccruedContractManufacturingServicesCurrent
95657
CY2017Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
824349
CY2018Q4 cue Accrued Contract Manufacturing Services Current
AccruedContractManufacturingServicesCurrent
160650
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
207440
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
111750
CY2018Q4 cue Accrued Contract Research Services Current
AccruedContractResearchServicesCurrent
145035
CY2017Q4 cue Accrued Contract Research Services Current
AccruedContractResearchServicesCurrent
21472
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
79188
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
97857
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1835600
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
648450
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0243
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0171
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0295
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0222
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.820
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.809
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.836
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.830
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1663221
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1089000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2800
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
17200
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2732221
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2500
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1422014
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.86
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.89
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.86
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M4D
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7173713
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2775363
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
15816662
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1682014
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2522000
CY2018Q4 cue Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Exercisable Intrinsic Fair Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfOptionsExercisableIntrinsicFairValuePerShare
4.70
CY2017Q4 cue Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Exercisable Intrinsic Fair Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfOptionsExercisableIntrinsicFairValuePerShare
7.50
CY2018 cue Number Of Tranches
NumberOfTranches
2
CY2018Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2500000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15738000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8424000
CY2018Q4 cue Deferred Tax Assets Tax Credit Carryforwards Research And Other
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther
1450000
CY2017Q4 cue Deferred Tax Assets Tax Credit Carryforwards Research And Other
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther
867000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1953000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
595000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3000
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
4000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19144000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9890000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19004000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9793000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
140000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
97000
CY2018Q4 cue Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
140000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.08
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M28D
CY2017Q4 cue Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
97000
CY2018 cue Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1.00
CY2017 cue Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1.00
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.04
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1432234000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.24
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.16
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.02
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.02
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.03
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.02
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.00
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.18
CY2018 cue Effective Income Tax Rate Reconciliation Foreign Withholding Taxes
EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxes
0.02
CY2017 cue Effective Income Tax Rate Reconciliation Foreign Withholding Taxes
EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxes
0.00
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.00
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 cue Tax Cuts And Jobs Act On Change In Tax Rate Deferred Tax Asset Income Tax Expense
TaxCutsAndJobsActOnChangeInTaxRateDeferredTaxAssetIncomeTaxExpense
4300000
CY2018 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
Upon execution of this lease agreement the Company prepaid three months of rent, two of which will be held in escrow and credited against future rent payments and one month that was applied to the first months rent. The Company also prepaid seven and one half months rent pursuant to an amendment to the lease agreement executed on June 18, 2018. These amounts were recorded to deposits and prepaid expenses, respectively at December 31, 2018
CY2018 cue Additional Description Of Lessee Leasing Arrangements Operating Leases
AdditionalDescriptionOfLesseeLeasingArrangementsOperatingLeases
Upon execution of this lease agreement the Company prepaid three months of rent which will be held in escrow and credited against future rent payments. The Company also prepaid twelve months rent pursuant to the lease agreement executed on September 20, 2018. These amounts were recorded to deposits and prepaid expenses, respectively at December 31, 2018.
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4461349000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4910521000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
10804104000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3311000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1976000

Files In Submission

Name View Source Status
0001564590-19-007832-index-headers.html Edgar Link pending
0001564590-19-007832-index.html Edgar Link pending
0001564590-19-007832.txt Edgar Link pending
0001564590-19-007832-xbrl.zip Edgar Link pending
cue-10k_20181231.htm Edgar Link pending
cue-20181231.xml Edgar Link completed
cue-20181231.xsd Edgar Link pending
cue-20181231_cal.xml Edgar Link unprocessable
cue-20181231_def.xml Edgar Link unprocessable
cue-20181231_lab.xml Edgar Link unprocessable
cue-20181231_pre.xml Edgar Link unprocessable
cue-ex1010_634.htm Edgar Link pending
cue-ex21_573.htm Edgar Link pending
cue-ex231_635.htm Edgar Link pending
cue-ex232_487.htm Edgar Link pending
cue-ex311_8.htm Edgar Link pending
cue-ex312_6.htm Edgar Link pending
cue-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g5stvhjhdgex000001.jpg Edgar Link pending
gbw5lbz41iiz000001.jpg Edgar Link pending
gbw5lbz41iiz000002.jpg Edgar Link pending
gbw5lbz41iiz000003.jpg Edgar Link pending
gbw5lbz41iiz000004.jpg Edgar Link pending
gbw5lbz41iiz000005.jpg Edgar Link pending
gbw5lbz41iiz000006.jpg Edgar Link pending
gbw5lbz41iiz000007.jpg Edgar Link pending
gbw5lbz41iiz000008.jpg Edgar Link pending
gbw5lbz41iiz000009.jpg Edgar Link pending
gbw5lbz41iiz000010.jpg Edgar Link pending
gbw5lbz41iiz000011.jpg Edgar Link pending
gbw5lbz41iiz000012.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending